User profiles for S.M. Metcalfe
Su MetcalfeSenior Research Associate Univeristy of Cambridge Verified email at cam.ac.uk Cited by 4112 |
[HTML][HTML] Mesenchymal stem cells and management of COVID-19 pneumonia
SM Metcalfe - Medicine in drug discovery, 2020 - Elsevier
Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia associated with
rapid virus replication. Arising in Wuhan China December 2019, the current COVID-19 …
rapid virus replication. Arising in Wuhan China December 2019, the current COVID-19 …
[HTML][HTML] Peptidylproline cis/trans isomerases
A Galat, SM Metcalfe - Progress in biophysics and molecular biology, 1995 - Elsevier
The immune system of mammals developed an exquisite ability to discriminate between"
self" and" non-self" with non-self normally being potential pathogens of foreign origin. This …
self" and" non-self" with non-self normally being potential pathogens of foreign origin. This …
Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6
…, Q Zhou, P Putheti, TM Fahmy, TB Strom, SM Metcalfe - Cell Cycle, 2009 - Taylor & Francis
… Metcalfe SM. Axotrophin and leukemia inhibitory factor (LIF) in transplantation tolerance. …
Chen Z, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune …
Chen Z, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune …
LIF in the regulation of T-cell fate and as a potential therapeutic
SM Metcalfe - Genes & Immunity, 2011 - nature.com
At the heart of lineage commitment within the adaptive immune response is the intrinsic genetic
plasticity of the naive peripheral T lymphocyte (T cell). Primary activation by presentation …
plasticity of the naive peripheral T lymphocyte (T cell). Primary activation by presentation …
[HTML][HTML] Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice
H Dong, TM Fahmy, SM Metcalfe, SL Morton, X Dong… - PloS one, 2012 - journals.plos.org
Two major hurdles need to be surmounted for cell therapy for diabetes: (i) allo-immune rejection
of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) …
of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) …
The interaction of small molecules with spin-labelled erythrocyte membranes
WL Hubbell, JC Metcalfe, SM Metcalfe… - … et Biophysica Acta (BBA …, 1970 - Elsevier
The spectra of non-covalent spin labels have been examined in the presence of erythrocyte
membranes and their separated lipid and protein components. Evidence has been obtained …
membranes and their separated lipid and protein components. Evidence has been obtained …
Targeted nanotherapy for induction of therapeutic immune responses
SM Metcalfe, TM Fahmy - Trends in molecular medicine, 2012 - cell.com
Nanotechnology permits the design of therapeutic devices with defined structure and
molecular composition. Modular designs employing surface-bound ligands provide specific …
molecular composition. Modular designs employing surface-bound ligands provide specific …
Leukemia inhibitory factor is linked to regulatory transplantation tolerance
SM Metcalfe, TJ Watson, S Shurey, E Adams… - …, 2005 - journals.lww.com
Background. The specific regulation of allo-tolerance in vivo occurs within a complex
microenvironment and involves co-operation between a small proportion of different cell types …
microenvironment and involves co-operation between a small proportion of different cell types …
Multiple sclerosis and the LIF/IL-6 axis: use of nanotechnology to harness the tolerogenic and reparative properties of LIF
Leukaemia inhibitory factor (LIF) plays a critical role in" stemness" versus" differentiation", a
property that underpins the core value of LIF as a therapeutic for both the treatment of …
property that underpins the core value of LIF as a therapeutic for both the treatment of …
[HTML][HTML] Multiple sclerosis: LIFNano-CD4 for trojan horse delivery of the neuro-protective biologic “LIF” into the brain: Preclinical proof of concept
… This research was supported by grants to SM including GMSI 2014 Award from Merck Serono
and grants from Innovate UK including Smart Award 2015 and Biomedical Catalyst Award …
and grants from Innovate UK including Smart Award 2015 and Biomedical Catalyst Award …